Xiaoxin Chen

1.4k total citations
46 papers, 988 citations indexed

About

Xiaoxin Chen is a scholar working on Surgery, Pharmacology and Epidemiology. According to data from OpenAlex, Xiaoxin Chen has authored 46 papers receiving a total of 988 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Surgery, 10 papers in Pharmacology and 9 papers in Epidemiology. Recurrent topics in Xiaoxin Chen's work include Influenza Virus Research Studies (4 papers), Eosinophilic Esophagitis (4 papers) and Esophageal Cancer Research and Treatment (4 papers). Xiaoxin Chen is often cited by papers focused on Influenza Virus Research Studies (4 papers), Eosinophilic Esophagitis (4 papers) and Esophageal Cancer Research and Treatment (4 papers). Xiaoxin Chen collaborates with scholars based in China, United States and Hong Kong. Xiaoxin Chen's co-authors include Chung S. Yang, Sandeep Sood, Zheng Sun, Ning Li, Fengde Chen, Peng Wang, Flordeliza Y. Bondoc, Guang‐Yu Yang, Stephen K. Curtis and Su Wang and has published in prestigious journals such as PLoS ONE, Scientific Reports and Clinical Cancer Research.

In The Last Decade

Xiaoxin Chen

43 papers receiving 969 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoxin Chen China 17 318 213 203 110 104 46 988
Wenyu Wu China 20 470 1.5× 83 0.4× 165 0.8× 85 0.8× 115 1.1× 62 1.1k
Huahong Wang China 19 731 2.3× 125 0.6× 123 0.6× 61 0.6× 72 0.7× 58 1.2k
Yingchao Wang China 19 421 1.3× 128 0.6× 61 0.3× 88 0.8× 180 1.7× 64 1.1k
Liping Xu China 22 659 2.1× 175 0.8× 108 0.5× 174 1.6× 270 2.6× 55 1.4k
Shuang Sun China 21 549 1.7× 84 0.4× 79 0.4× 138 1.3× 128 1.2× 56 1.4k
Hiroshi Azuma Japan 14 394 1.2× 129 0.6× 111 0.5× 76 0.7× 87 0.8× 40 1.2k
Michela Falco Italy 12 445 1.4× 77 0.4× 98 0.5× 72 0.7× 142 1.4× 15 967
Satoru Matsuyama Japan 14 400 1.3× 140 0.7× 50 0.2× 130 1.2× 120 1.2× 30 1.3k
Venkata Ramireddy Narala India 20 571 1.8× 97 0.5× 72 0.4× 187 1.7× 131 1.3× 51 1.2k
David C. Montrose United States 23 794 2.5× 168 0.8× 242 1.2× 93 0.8× 256 2.5× 40 1.5k

Countries citing papers authored by Xiaoxin Chen

Since Specialization
Citations

This map shows the geographic impact of Xiaoxin Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoxin Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoxin Chen more than expected).

Fields of papers citing papers by Xiaoxin Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoxin Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoxin Chen. The network helps show where Xiaoxin Chen may publish in the future.

Co-authorship network of co-authors of Xiaoxin Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoxin Chen. A scholar is included among the top collaborators of Xiaoxin Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoxin Chen. Xiaoxin Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Li, Haijun, et al.. (2025). Pharmacokinetic insights of onradivir in influenza treatment to inform pediatric dosing selection in clinical trial. Drug Metabolism and Disposition. 53(11). 100171–100171. 1 indexed citations
3.
Wang, Kun, Haijun Li, Youyun Li, et al.. (2024). Model informed dose regimen optimizing in development of leritrelvir for the treatment of mild or moderate COVID-19. Frontiers in Pharmacology. 15. 1449583–1449583. 4 indexed citations
4.
Lin, Shu‐Hong, et al.. (2024). Construction and evaluation of endometriosis diagnostic prediction model and immune infiltration based on efferocytosis-related genes. Frontiers in Molecular Biosciences. 10. 1298457–1298457. 3 indexed citations
5.
Sun, Bowen, et al.. (2024). Luoshi Neiyi Prescription inhibits estradiol synthesis and inflammation in endometriosis through the HIF1A/EZH2/SF-1 pathway. Journal of Ethnopharmacology. 335. 118659–118659. 2 indexed citations
6.
Li, Haijun, Yue Hu, Yuting Yang, et al.. (2024). Dose finding for ZSP1601 in patients with nonalcoholic steatohepatitis using population pharmacokinetics and exposure–response approach. European Journal of Pharmaceutical Sciences. 199. 106808–106808. 3 indexed citations
7.
Chen, Xiaoxin, et al.. (2023). Bibliometric analysis of the effects of mental fatigue on athletic performance from 2001 to 2021. Frontiers in Psychology. 13. 1019417–1019417. 10 indexed citations
8.
Chen, Xiaoxin, et al.. (2023). Blood urea nitrogen to creatinine ratio is associated with physical frailty in older-aged Chinese: a cross-sectional study. Aging Clinical and Experimental Research. 35(3). 581–589. 4 indexed citations
9.
Chen, Xiaoxin, Qinhai Ma, Manyu Zhao, et al.. (2023). Preclinical Study of ZSP1273, a Potent Antiviral Inhibitor of Cap Binding to the PB2 Subunit of Influenza A Polymerase. Pharmaceuticals. 16(3). 365–365. 12 indexed citations
11.
Liu, Yufeng, Jianjiang Zhang, W. F. Mader, et al.. (2021). The role of miR-199b-3p in regulating Nrf2 pathway by dihydromyricetin to alleviate septic acute kidney injury. Free Radical Research. 55(6). 634–644. 17 indexed citations
12.
Zhao, Manyu, Qianru Zhang, Ying Lu, et al.. (2020). The pharmacodynamic and differential gene expression analysis of PPAR α/δ agonist GFT505 in CDAHFD-induced NASH model. PLoS ONE. 15(12). e0243911–e0243911. 18 indexed citations
14.
Chen, Xiaoxin, et al.. (2019). Buteyko breathing technique for obstructive Eustachian tube dysfunction: Preliminary results from a randomized controlled trial. American Journal of Otolaryngology. 40(5). 645–649. 4 indexed citations
15.
Pei, Heying, Linhong He, Mingfeng Shao, et al.. (2018). Discovery of a highly selective JAK3 inhibitor for the treatment of rheumatoid arthritis. Scientific Reports. 8(1). 5273–5273. 33 indexed citations
16.
Chen, Xiaoxin, Ckf Lee, Stephen Cho Wing Sze, et al.. (2018). Dendrobine targeting JNK stress signaling to sensitize chemotoxicity of cisplatin against non-small cell lung cancer cells in vitro and in vivo. Phytomedicine. 53. 18–27. 47 indexed citations
17.
Feng, Huiling, Ling Tian, Wei‐Ming Chai, et al.. (2014). Isolation and Purification of Condensed Tannins from Flamboyant Tree and Their Antioxidant and Antityrosinase Activities. Applied Biochemistry and Biotechnology. 173(1). 179–192. 11 indexed citations
18.
Bulsiewicz, William J., Hannah P. Kim, Evan S. Dellon, et al.. (2012). Safety and Efficacy of Endoscopic Mucosal Therapy With Radiofrequency Ablation for Patients With Neoplastic Barrett's Esophagus. Clinical Gastroenterology and Hepatology. 11(6). 636–642. 76 indexed citations
19.
Chen, Xiaoxin, Sandeep Sood, Chung S. Yang, Ning Li, & Zheng Sun. (2006). Five-Lipoxygenase Pathway of Arachidonic Acid Metabolism in Carcinogenesis and Cancer Chemoprevention. Current Cancer Drug Targets. 6(7). 613–622. 59 indexed citations
20.
Chen, Xiaoxin. (2002). Overexpression of glucose-regulated protein 94 (Grp94) in esophageal adenocarcinomas of a rat surgical model and humans. Carcinogenesis. 23(1). 123–130. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026